Loading...

FDA Authorizes First At-Home Sample Collection Test for COVID-19

April 21, 2020 by Dan McCue
FDA Authorizes First At-Home Sample Collection Test for COVID-19
This undated electron microscope image made available by the U.S. National Institutes of Health in February 2020 shows the Novel Coronavirus SARS-CoV-2. (NIAID-RML via AP)

WASHINGTON – The Food and Drug Administration Tuesday approved the first diagnostic test for the coronavirus that allows people to collect their sample at home — a development that could greatly expand testing options in states fighting to corral the outbreak.

The COVID-19 RT-PCR from LabCorp will initially only be available to health care workers and first responders under a doctor’s orders.

The sample, collected via swab, will still have to be shipped for processing back to LabCorp, which operates diagnostic labs throughout the U.S.

Before gaining access to the home test, people are screened using an online questionnaire.

If authorized by a physician, LabCorp will ship a testing kit to their home.

The kit includes cotton swabs, a collection tube, an insulated pouch and box to ship the specimen back to LabCorp. To take a sample, a cotton swab is swirled in each nostril. The test results are posted online to a secure company website.

The company said it will make the test kit available in the coming weeks. Each will cost $119. The kits will not be available in Maryland, New Jersey, New York and Rhode Island. Those states have laws prohibiting testing with at-home kits.

FDA Commissioner Stephan Hawn said in a statement the agency authorized the self-swab test based on data showing it is “as safe and accurate as sample collection at a doctor’s office, hospital or other testing site.”

“Throughout this pandemic we have been facilitating test development to ensure patients access to accurate diagnostics, which includes supporting the development of reliable and accurate at-home sample collection options,” he said.

“The FDA’s around-the-clock work since this outbreak began has resulted in the authorization of more than 50 diagnostic tests and engagement with over 350 test developers,” he continued.

The FDA said it will continue to work with test developers to determine whether or not Q-tip-style cotton swabs can be used safely and effectively with other tests.

In The News

Health

Voting

Health

A Key Inflation Gauge Rose 5.8% in 2021, Most in 39 Years

WASHINGTON (AP) — A measure of prices that is closely tracked by the Federal Reserve rose 5.8% last year, the... Read More

WASHINGTON (AP) — A measure of prices that is closely tracked by the Federal Reserve rose 5.8% last year, the sharpest increase since 1982, as brisk consumer spending collided with snarled supply chains to raise the costs of food, furniture, appliances and other goods. The report... Read More

January 27, 2022
by Alexa Hornbeck
Federal Efforts Aim to Combat ‘Silent Pandemic’ of Antimicrobial Resistance  

WASHINGTON — A recent study published in the Lancet is the first to provide estimates that the global death toll... Read More

WASHINGTON — A recent study published in the Lancet is the first to provide estimates that the global death toll from antimicrobial resistance is greater than that of HIV or malaria. “It was our role to provide the most comprehensive results available for these [global health]... Read More

January 26, 2022
by Alexa Hornbeck
EPA and WHO Sign Memorandum With New Actions to Protect Human Health

The U.S. Environmental Protection Agency and World Health Organization recently signed a five-year Memorandum of Understanding with new actions for protecting human health... Read More

The U.S. Environmental Protection Agency and World Health Organization recently signed a five-year Memorandum of Understanding with new actions for protecting human health and the environment. “The COVID-19 pandemic has highlighted the intimate links between humans and our environment,” said Dr. Tedros Adhanom Ghebreyesus, WHO director-general, in a written statement. ... Read More

January 26, 2022
by Alexa Hornbeck
Black Patients With Dementia More Likely to Receive Aggressive Care in Nursing Homes 

A recent study published in JAMA Internal Medicine shows that Black nursing home residents with advanced dementia likely receive more aggressive care... Read More

A recent study published in JAMA Internal Medicine shows that Black nursing home residents with advanced dementia likely receive more aggressive care than non-Black residents.  A team of researchers from Massachusetts, Tennessee, Georgia and North Carolina conducted the qualitative study with 169 staff interviews in 14 nursing homes... Read More

January 26, 2022
by Alexa Hornbeck
UCSD Offers Magnetic Stimulation for Patients With Treatment-Resistant Depression 

The University of California San Diego Health now offers a new treatment for patients with treatment-resistant depression, called transcranial magnetic stimulation.... Read More

The University of California San Diego Health now offers a new treatment for patients with treatment-resistant depression, called transcranial magnetic stimulation. TMS is a treatment approved by the U.S. Food and Drug Administration to stimulate nerve cells in areas of the brain associated with major depression. The... Read More

January 26, 2022
by Alexa Hornbeck
Rhode Island Delays Enforcement of Law to Increase Staffing in Nursing Homes 

In Rhode Island, Gov. Dan McKee recently signed an executive order to halt the enforcement of the Nursing Home Staffing and Quality Care... Read More

In Rhode Island, Gov. Dan McKee recently signed an executive order to halt the enforcement of the Nursing Home Staffing and Quality Care Act, which he signed into law last May to give nursing homes across the state a higher staff-to-patient ratio.  The Nursing Home Staffing and Quality Care... Read More

News From The Well
Exit mobile version